Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

4:15 PM - 4:25 PM PT

1067 - Toxicity and Clinical Outcomes of Proton vs. Photon Volumetric Modulated Arc Therapy Craniospinal Irradiation for Solid Tumor Leptomeningeal Carcinomatosis
Speaker: Lamanilao, Gene, MD, MS, BS - University of California San Diego, La Jolla, CA
4:15 PM - 4:20 PM PT

1074 - Implications on Radiation Treatment Planning of 18F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET/CT
Speaker: Eakin, Adam, MD - Oregon Health and Science University, Portland, OR
4:20 PM - 4:25 PM PT

1063 - Dose-Volume Predictors for Radiation Esophagitis in Breast Cancer Patients Undergoing Conventional Fractionated Regional Nodal Radiotherapy: A Prospective Study
Speaker: Wang, Dan-Qiong, MD - National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade, ???, Beijing
4:20 PM - 4:25 PM PT

1075 - Analysis on the Predictive Power of PSA-Nadir <0.1 ng/ml after Salvage Radiotherapy for PSA-Recurrence after Radical Prostatectomy - Subanalysis of the Phase-III Dose Escalation SAKK 09/10 Study and Comparison with a Retrospective Cohort
Speaker: Wiegel, Thomas, MD - University Hospital Ulm, Ulm, Baden-Wurt
4:20 PM - 4:30 PM PT

343 - Phase 3 Study of Pembrolizumab (Pembro) + Adjuvant Chemotherapy (CT) ± Radiotherapy (RT) for Newly Diagnosed, High-Risk Endometrial Cancer (EC): Exploratory Analysis of Disease-Specific-Free Survival (DSFS) and Safety by Radiation Usage
Speaker: Mayadev, Jyoti, MD, FASTRO - UCSD, La JOlla, CA
4:20 PM - 4:30 PM PT

348 - Impact of AI-Based Coronary Artery Calcium (CAC) Scores and Heart Dose on Survival in Locally-Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): A Secondary Analysis of RTOG 0617
Speaker: Haldar, Nilanjan, MD, BS - Thomas Jefferson University, Philadelphia, PA
4:25 PM - 4:35 PM PT

1068 - Results of a Randomized Phase 2 Study of a Novel Superoxide Dismutase Mimetic in Patients with Multiple Brain Metastases undergoing Whole-Brain Radiotherapy
Speaker: Kirkpatrick, John, MD, PhD, FASTRO - Duke University Medical Center, Chapel Hill, North Carolina
4:25 PM - 4:30 PM PT

1076 - Early Results from a Randomized Phase II Trial Testing Apalutamide and Stereotactic Body Radiation Therapy for Low-Burden Mhspc (NCT05717660)
Speaker: Loi, Mauro, MD - Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany
4:30 PM - 4:35 PM PT

1065 - Patient Reported Outcomes following Accelerated Partial Breast vs. Ultrahypofractionated/Hypofractionated Whole Breast: A Single Institution Comparison Study
Speaker: Rau, Allison, MD, MS - Arthur JE Child Comprehensive Cancer Centre, Calgary, AB
4:30 PM - 4:35 PM PT

1077 - A Dynamic Treatment Strategy for Oligometastatic CSPC: Integrating Molecular Imaging and SBRT to Personalize Systemic Therapy Intensification and De-Intensification
Speaker: Bettoli, Piero, MD, MS - Instituto Nacional del Cancer, Santiago, Region Met
4:30 PM - 4:40 PM PT

344 - Nimotuzumab Plus Concurrent Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma: Updated Follow-up from the Randomized, Phase 3 CC3 Study
Speaker: Wang, Junjie, MD - Peking University Third Hospital, Beijing, Beijing
4:30 PM - 4:40 PM PT

349 - Epicardial Fat as a Radiomic Predictor of Cardiac Outcomes Following Thoracic Radiotherapy for Lung Cancer
Speaker: Jiao, Qiao, MS, BS, BA - Harvard Medical School, Boston, MI